Literature DB >> 26243581

Chemical Constituents, Quality Control, and Bioactivity of Epimedii Folium (Yinyanghuo).

Xiao-Jia Chen1, Zheng-Hai Tang1, Xi-Wen Li1,2, Cai-Xiang Xie3, Jin-Jian Lu1, Yi-Tao Wang1.   

Abstract

Epimedii Folium (Yinyanghuo in Chinese) is one of the most commonly used traditional Chinese medicines. Its main active components are flavonoids, which exhibit multiple biological activities, such as promotion of bone formation and sexual function, protection of the nervous system, and prevention of cardiovascular diseases. Flavonoids also show anti-inflammatory and anticancer effects. Various effective methods, including genetic and chemical approaches, have been developed for the quality control of Yinyanghuo. In this review, the studies conducted in the last decade about the chemical constituents, quality control, and bioactivity of Yinyanghuo are summarized and discussed.

Entities:  

Keywords:  Bioactivity; Chemical Constituents; Epimedium; Flavonoids; Quality Control; Review

Mesh:

Substances:

Year:  2015        PMID: 26243581     DOI: 10.1142/S0192415X15500494

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  13 in total

1.  Two new prenylflavonoids from Epimedii Herba and their inhibitory effects on advanced glycation end-products.

Authors:  Keisuke Nakashima; Hiroyuki Miyashita; Hitoshi Yoshimitsu; Yukio Fujiwara; Ryoji Nagai; Tsuyoshi Ikeda
Journal:  J Nat Med       Date:  2016-01-12       Impact factor: 2.343

Review 2.  Molecular mechanisms regulating the pharmacological actions of icariin with special focus on PI3K-AKT and Nrf-2 signaling pathways.

Authors:  Aanchal Verma; Kritika Aggarwal; Ritik Agrawal; Kajal Pradhan; Ahsas Goyal
Journal:  Mol Biol Rep       Date:  2022-08-08       Impact factor: 2.742

3.  Osteoblasts Proliferation and Differentiation Stimulating Activities of the Main Components of Epimedii folium.

Authors:  Mingming Liu; Haiyan Xu; Yong Ma; Jian Cheng; Zhen Hua; Guicheng Huang
Journal:  Pharmacogn Mag       Date:  2017 Jan-Mar       Impact factor: 1.085

4.  Comparison of the Active Compositions between Raw and Processed Epimedium from Different Species.

Authors:  Huamei Zhang; Hui Wang; Juan Wei; Xiaopeng Chen; Mengjie Sun; Huizi Ouyang; Jia Hao; Yanxu Chang; Zhiying Dou; Jun He
Journal:  Molecules       Date:  2018-07-07       Impact factor: 4.411

5.  Potential of Icariin Metabolites from Epimedium koreanum Nakai as Antidiabetic Therapeutic Agents.

Authors:  Da Hye Kim; Hyun Ah Jung; Hee Sook Sohn; Jin Woong Kim; Jae Sue Choi
Journal:  Molecules       Date:  2017-06-13       Impact factor: 4.411

6.  Effects of Icariin on Atherosclerosis and Predicted Function Regulatory Network in ApoE Deficient Mice.

Authors:  Yibing Zhang; Xiaoyan Ma; Xiangjun Li; Tong Zhang; Meng Qin; Liqun Ren
Journal:  Biomed Res Int       Date:  2018-11-06       Impact factor: 3.411

Review 7.  A preliminary review of studies on adaptogens: comparison of their bioactivity in TCM with that of ginseng-like herbs used worldwide.

Authors:  Lian-Ying Liao; Yi-Fan He; Li Li; Hong Meng; Yin-Mao Dong; Fan Yi; Pei-Gen Xiao
Journal:  Chin Med       Date:  2018-11-16       Impact factor: 5.455

8.  A network pharmacology approach to explore active compounds and pharmacological mechanisms of epimedium for treatment of premature ovarian insufficiency.

Authors:  Huishan Zhao; Yinghua Shan; Zhi Ma; Mingwei Yu; Benjiao Gong
Journal:  Drug Des Devel Ther       Date:  2019-08-22       Impact factor: 4.162

9.  A Network Pharmacology Approach to Estimate Potential Targets of the Active Ingredients of Epimedium for Alleviating Mild Cognitive Impairment and Treating Alzheimer's Disease.

Authors:  Xianwei Gao; Shengnan Li; Chao Cong; Yuejiao Wang; Lianwei Xu
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-28       Impact factor: 2.629

10.  Icaritin Inhibits Collagen Degradation-Related Factors and Facilitates Collagen Accumulation in Atherosclerotic Lesions: A Potential Action for Plaque Stabilization.

Authors:  Zong-Kang Zhang; Jie Li; De-Xin Yan; Wing-Nang Leung; Bao-Ting Zhang
Journal:  Int J Mol Sci       Date:  2016-01-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.